Loading...
Efficacy and safety of tiotropium Respimat(®) SMI in COPD in two 1-year randomized studies
Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat(®) Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV(1) response, Mahler Transition Dyspnea Index [TDI] and St George’s Re...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921687/ https://ncbi.nlm.nih.gov/pubmed/20714373 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|